Outsourcing STREAM

  1. A Different Kind Of CRO 1/30/2023

    Altasciences is an award-winning, forward-thinking, mid-size early phase contract research organization, in Canada and the U.S., offering biopharmaceutical companies of all sizes a proven, flexible approach to early drug development.

  2. Big Impact With A Personal Touch 1/30/2023

    Transforming lives. Improving human health. Bringing new therapies to life. Altasciences' CRO and CDMO services deliver.

  3. The Heart Of The Matter: Early Vs. Late QT Prolongation Testing 2/8/2023

    Dr. Beatrice Setnik, Altasciences' Chief Scientific Officer, walks through the differences between early and late QT prolongation testing.

  4. Getting Buy-In For Disclosure As A Service 6/3/2020

    Clinical trial disclosure teams often have a tough time convincing upper management on the benefits of Disclosure as a Service. Hear how two sponsors “sold” the idea of outsourcing this function. Watch the short TrialScope interview.

  5. Streamlining Patient Access To Cell And Gene Therapies 12/21/2023

    Learn about the obstacles patients encounter when seeking CGTs and explore how technology and patient services can empower manufacturers and clinical teams to help patients overcome barriers.

  6. Proactive Drug Development: Explained 1/30/2023

    Watch this short video to learn about Proactive Drug Development with Altasciences.

  7. We Are Altasciences: Proactive Drug Development 1/30/2023

    When you partner with Altasciences, you get a single source outsourcing partner who knows your program from end to end and who can anticipate your needs, for a seamless and simplified experience.

  8. Altasciences Has You Covered From Coast To Coast 1/30/2023

    With your success in mind, we designed an integrated early phase drug development offering with eight locations, to get you from lead candidate selection to clinical proof of concept, and beyond.

  9. Flipping The Drug Development Industry On Its Head 6/18/2024

    The video dives into the obstacles of the traditional outsourcing relationship between CROs and sponsors, and how Altasciences has broken from tradition to offer an alternative model.

  10. How Sponsors Turn Disclosure As A Service Into A Strategic Advantage 5/18/2020

    In this panel discussion, Teva and Lung Biotechnology disclosure experts discuss why they opted for disclosure as a service. They will detail how it helps them safeguard regulatory compliance and mitigate risk.